Form 8-K - Current report:
SEC Accession No. 0001213900-24-073351
Filing Date
2024-08-28
Accepted
2024-08-28 15:59:12
Documents
18
Period of Report
2024-08-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea021270001-8k_60degrees.htm   iXBRL 8-K 30844
2 PRESS RELEASE DATED AS OF AUGUST 28, 2024 ea021270001ex99-1_60degrees.htm EX-99.1 8869
7 GRAPHIC image_001.gif GRAPHIC 43
8 GRAPHIC image_002.gif GRAPHIC 35
9 GRAPHIC image_001.jpg GRAPHIC 4094
  Complete submission text file 0001213900-24-073351.txt   270567

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sxtp-20240826.xsd EX-101.SCH 3795
4 XBRL DEFINITION FILE sxtp-20240826_def.xml EX-101.DEF 26656
5 XBRL LABEL FILE sxtp-20240826_lab.xml EX-101.LAB 36762
6 XBRL PRESENTATION FILE sxtp-20240826_pre.xml EX-101.PRE 25280
21 EXTRACTED XBRL INSTANCE DOCUMENT ea021270001-8k_60degrees_htm.xml XML 5949
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 241255197
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)